Autobio Diagnostics (603658.SH) and its subsidiaries have obtained multiple medical device registration certificates.
Antu Biology (603658.SH) announced that the company and its wholly-owned subsidiary Antu Experimental Instrument (Zhengzhou) Co., Ltd. ("Antu Instrument") recently received multiple medical device registration certificates issued by the Henan Provincial Drug Administration.
Autobio Diagnostics (603658.SH) announced that the company and its wholly-owned subsidiary, Antu Laboratory Instrument (Zhengzhou) Co., Ltd. (referred to as "Antu Instrument"), recently received multiple medical device registration certificates issued by the Henan Provincial Drug Administration.
The acquisition of the above-mentioned medical device registration certificates further enriches the company's product menu, continuously meeting market demand. It is an effective supplement to the company's existing testing products and can gradually improve the overall competitiveness of the company's products. In the short term, the impact on the company's operating performance is minimal.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


